Tenon Medical, Inc. is a healthcare company focused on developing innovative solutions for the treatment of sacroiliac joint disorders. By leveraging advanced medical technology, the company aims to improve surgical outcomes and enhance patient recovery through its minimally invasive procedures and products. Tenon Medical is committed to addressing the unmet needs of patients suffering from chronic pain related to sacroiliac joint dysfunction by providing effective, safe, and durable treatment options, thus contributing to the ongoing advancement of orthopedic and pain management practices. Read More
LOS GATOS, CA / ACCESS Newswire / August 5, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the second quarter 2025 ended June 30, 2025 after market close on Wednesday, August 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Stay updated with the latest market activity on Friday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
LOS GATOS, CA / ACCESS Newswire / April 29, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the first quarter 2025 ended March 31, 2025 after market close on Tuesday, May 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
